WE AIM TO FIGHT THE HEALTH THREAT
In the written statement, one of the founders of BioNTech, Prof. Dr. Uğur Şahin said, “The agreement aims to develop a new m-RNA-based vaccine against shingles using the expertise and resources of both companies.” statements were made.
Mikael Dolsten, Head of Pfizer’s Global Research, Development and Medicine Division, said: “Pfizer and BioNTech have developed the world’s first m-RNA vaccine against the most devastating epidemic of the century. With this agreement, we continue our scientific discoveries and advance m-RNA technology to combat another health threat. We aim to.” used the phrase.
KNOWN AS A CONTAGIOUS NERVE INFECTION
For the first time, the m-RNA-based vaccine developed by Pfizer and BioNTech against Kovid-19 in 2020 fights the virus by using a “messenger RNA” molecule, a genetic material to trigger the immune response. Shingles, caused by the Varicella zoster virus, which also causes chickenpox, is known as a contagious nerve infection.
Shingles, which can occur all over the body, in many cases appears as a single strip of blisters that covers the left or right side of the body.
Source: A HABER by www.ahaber.com.tr.
*The article has been translated based on the content of A HABER by www.ahaber.com.tr. If there is any problem regarding the content, copyright, please leave a report below the article. We will try to process as quickly as possible to protect the rights of the author. Thank you very much!
*We just want readers to access information more quickly and easily with other multilingual content, instead of information only available in a certain language.
*We always respect the copyright of the content of the author and always include the original link of the source article.If the author disagrees, just leave the report below the article, the article will be edited or deleted at the request of the author. Thanks very much! Best regards!